1. Home
  2. KRYS vs ABCB Comparison

KRYS vs ABCB Comparison

Compare KRYS & ABCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • ABCB
  • Stock Information
  • Founded
  • KRYS 2015
  • ABCB 1971
  • Country
  • KRYS United States
  • ABCB United States
  • Employees
  • KRYS N/A
  • ABCB N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • ABCB Major Banks
  • Sector
  • KRYS Health Care
  • ABCB Finance
  • Exchange
  • KRYS Nasdaq
  • ABCB Nasdaq
  • Market Cap
  • KRYS 3.6B
  • ABCB 4.2B
  • IPO Year
  • KRYS 2017
  • ABCB N/A
  • Fundamental
  • Price
  • KRYS $133.05
  • ABCB $60.90
  • Analyst Decision
  • KRYS Strong Buy
  • ABCB Buy
  • Analyst Count
  • KRYS 8
  • ABCB 6
  • Target Price
  • KRYS $211.13
  • ABCB $69.83
  • AVG Volume (30 Days)
  • KRYS 320.8K
  • ABCB 287.0K
  • Earning Date
  • KRYS 08-04-2025
  • ABCB 07-24-2025
  • Dividend Yield
  • KRYS N/A
  • ABCB 1.31%
  • EPS Growth
  • KRYS 109.01
  • ABCB 31.20
  • EPS
  • KRYS 4.16
  • ABCB 5.38
  • Revenue
  • KRYS $333,448,000.00
  • ABCB $1,100,260,000.00
  • Revenue This Year
  • KRYS $44.05
  • ABCB $12.06
  • Revenue Next Year
  • KRYS $46.15
  • ABCB $6.18
  • P/E Ratio
  • KRYS $31.77
  • ABCB $11.34
  • Revenue Growth
  • KRYS 247.53
  • ABCB 13.98
  • 52 Week Low
  • KRYS $122.80
  • ABCB $47.05
  • 52 Week High
  • KRYS $219.34
  • ABCB $74.56
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 44.16
  • ABCB 49.32
  • Support Level
  • KRYS $127.99
  • ABCB $59.54
  • Resistance Level
  • KRYS $143.20
  • ABCB $63.66
  • Average True Range (ATR)
  • KRYS 4.23
  • ABCB 1.06
  • MACD
  • KRYS 1.01
  • ABCB -0.31
  • Stochastic Oscillator
  • KRYS 44.48
  • ABCB 33.01

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About ABCB Ameris Bancorp

Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. Ameris intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.

Share on Social Networks: